Doctor profile · Federal record
Dr. Christopher Rumplik, PA-C
Physician Assistant · Agawam, MA
- NPI 1144847286
- 6 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
200 Silver St Unit 106
Agawam, MA 010013067
(413) 341-5350
Credentials & registration
- NPI registered
- July 2020 — 6 yrs on file
- Profile last updated
- December 18, 2025
- Year of graduation
- 2020 — 6 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144847286. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
481
Distinct HCPCS
10
Medicare allowed
$24,279
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 73 | 15 | $6 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 52 | 52 | $97 | |
11102 |
Biopsy of related skin growth, first growth | 47 | 46 | $88 | |
99348 |
Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | 40 | 37 | $66 | |
99342 |
Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | 33 | 33 | $67 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 27 | 27 | $68 | |
17000 |
Destruction of precancer skin growth, 1 growth | 26 | 26 | $39 | |
87804 |
Detection test by immunoassay with direct visual observation for influenza virus | 26 | 13 | $16 | |
11103 |
Biopsy of related skin growth, each additional growth | 25 | 17 | $45 | |
99349 |
Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | 23 | 20 | $109 |
In context: peer comparison
Among 4 peers in Agawam Physician Assistant, average services per provider: 64. This provider delivers 7.5× the peer median.Open Payments
Industry payments received
All-time total
$5,874
Transactions
243
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 40 | $1,043.70 | |
| E.R. Squibb & Sons, L.L.C. | 33 | $745.41 | |
| Ucb, INC. | 34 | $577.41 | |
| Janssen Biotech, INC. | 12 | $430.14 | |
| Arcutis Biotherapeutics, INC. | 26 | $374.06 | |
| Lilly USA, LLC | 11 | $369.59 | |
| Leo Pharma INC. | 15 | $331.92 | |
| Sun Pharmaceutical Industries INC. | 13 | $305.11 | |
| Regeneron Healthcare Solutions, INC. | 7 | $296.64 | |
| Incyte Corporation | 12 | $274.16 | |
| Novartis Pharmaceuticals Corporation | 16 | $242.20 | |
| Amgen INC. | 7 | $191.52 | |
| Pfizer INC. | 11 | $167.24 | |
| Tactile Systems Technology INC | 1 | $99.86 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 5 | $97.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
157
Patients
140
Total drug cost
$3,850
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 34 | 30 | $232 |
| Doxycycline Hyclate | Generic | 30 | 30 | $250 |
| Mupirocin | Generic | 25 | 24 | $154 |
| Ketoconazole | Generic | 20 | 15 | $237 |
| Fluorouracil | Generic | 18 | 15 | $1,312 |
| Prednisone | Generic | 15 | 14 | $38 |
| Tacrolimus | Generic | 15 | 12 | $1,627 |
Frequently asked questions
What is Dr. Christopher Rumplik's medical specialty?
Dr. Christopher Rumplik practices Physician Assistant in Agawam, MA.
Where does Dr. Christopher Rumplik practice?
Dr. Christopher Rumplik practices at 200 Silver St Unit 106, Agawam, MA 010013067. Office phone: 4133415350.
What is Dr. Christopher Rumplik's NPI?
Dr. Christopher Rumplik's National Provider Identifier (NPI) is 1144847286, issued by NPPES.
Does Dr. Christopher Rumplik accept Medicare assignment?
Dr. Christopher Rumplik does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Christopher Rumplik commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); New patient office or other outpatient visit (HCPCS 99203); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.